Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CITRIS-ALI: Vitamin C in Sepsis-Induced ALI
NCT02106975Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Apr 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in sepsis, acute lung injury (ALI), sponsored by Virginia Commonwealth University. Started Apr 2014; status: completed.
02
Drugs
ascorbic acid
03
Conditions
sepsisacute lung injury (ALI)
Beyond the preview
Go deeper on NCT02106975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106975.